0->"

Analyze Clinical Trial Reports (CTRs) and domain expert statements to ascertain semantic entailment or support. Focus on four CTR sections: (1) ELIGIBILITY CRITERIA, specifying conditions for patient inclusion, (2) INTERVENTION, detailing treatment specifics such as type, dosage, frequency, and duration, (3) RESULTS, summarizing participant count, outcome measures, units, and conclusions, and (4) ADVERSE EVENTS, documenting observed patient signs and symptoms. Cross-examine these sections with expert statements, ensuring claims are consistent with, supported by, and non-contradictory to the CTRs' content.
----------
1->"

Analyze Clinical Trial Reports (CTRs) and domain expert statements to ascertain semantic entailment or support. Focus on four CTR sections: (1) ELIGIBILITY CRITERIA, specifying conditions for patient inclusion, (2) INTERVENTION, detailing treatment specifics such as type, dosage, frequency, and duration, (3) RESULTS, summarizing participant count, outcome measures, units, and conclusions, and (4) ADVERSE EVENTS, documenting observed patient signs and symptoms. Cross-examine these sections with expert statements, ensuring claims are consistent with, supported by, and non-contradictory to the CTRs' content.
----------
2->"

Analyze Clinical Trial Reports (CTRs) and domain expert statements to ascertain semantic entailment or support. Focus on four CTR sections: (1) ELIGIBILITY CRITERIA, specifying conditions for patient inclusion, (2) INTERVENTION, detailing treatment specifics such as type, dosage, frequency, and duration, (3) RESULTS, summarizing participant count, outcome measures, units, and conclusions, and (4) ADVERSE EVENTS, documenting observed patient signs and symptoms. Cross-examine these sections with expert statements, ensuring claims are consistent with, supported by, and non-contradictory to the CTRs' content.
----------
3->

Conduct a thorough analysis of Clinical Trial Reports (CTRs) in conjunction with expert insights to evaluate semantic alignment or entailment. Pay particular attention to four critical components within the CTRs: (1) ELIGIBILITY CRITERIA, detailing patient inclusion parameters, (2) INTERVENTION, specifying treatment particulars such as type, dosage, administration frequency, and treatment duration, (3) RESULTS, summarizing participant numbers, outcome measures, units of measurement, and findings, and ( 4) ADVERSE EVENTS, documenting any observed patient symptoms. Ensure that these components are consistent with, corroborated by, and do not contradict expert analyses.
----------
4->

Critically evaluate Clinical Trial Reports (CTRs) and statements from domain experts to determine if there is semantic support or entailment. Pay particular attention to the following CTR sections: (1) ELIGIBILITY CRITERIA, which outlines the inclusion conditions for patients, (2) INTERVENTION, detailing the specifics of the treatment including type, dosage, frequency, and duration, (3) RESULTS, which should provide a summary of the number of participants, outcome measures, units of measurement, and conclusions, and (4) ADVERSE EVENTS, noting any observed patient signs and symptoms. Ensure that expert statements are in agreement with, corroborate, and do not contradict the information presented in these CTR sections.
----------
